ü Director of Chemical Appeals Division I, Reexamination and Invalidation Division, NMPA

ü Patent Legal Director，Johnson & Johnson

ü Global Head of IP，Sanofi

ü VP&Legal Director, Roche China

ü Partner, Sonderhoff & Einsel Law and Patent Office

ü Partner, Liu Shen & Associates

ü Vice President of intellectual property, LUYE PHARMA

ü Director of Intellectual Property Management Center，Jiangsu Hengrui Pharmaceuticals Co., Ltd

ü Intellectual Property Director,Jiangsu Nhwa Pharmaceutical Co., Ltd.

ü Head of IP, Juntuo Biomedical Technology

ü Intellectual Property Director,Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.

ü Partner, King & Wood Mallesons

ü Assistant Director-General, WIPO

ü Deputy Director of IP Department, Qilu Pharmaceutical

ü Partner, Han Kun LLP

ü VP of Business Development, TYK Medicines, Inc

ü IP Director, Eddingpharm

Interpretation of biomedical intellectual property laws and policies under the new situation

 Patent protection in the biomedical field under the new patent law

 The particularity of patent applications in the biological field

 Comparison of early dispute resolution systems for biopharmaceutical patents in China and the US

 International progress in drug trial data protection and related systems

R&D innovation and patent protection in the fields of biotechnology and medicine

 Innovative patent research and development trends in the field of biotechnology

 Exploration and development of patent application technologies in the fields of gene editing and genetic engineering technologies

 Opportunities and challenges brought by patent cliff

 Determination and cultivation of high-value patents

 Pharmaceutical enterprise trade secret protection and infringement risk prevention

Trends in biomedical R&D and patent protection from a global perspective

 Global biosimilar patent litigation and marketing review

 Extended means of protection for pharmaceutical products – SPC

 The impact of the US S.150 bill on the marketing of generic drugs and biosimilar drugs

 Practical Strategies for European Medical Invention Patent Application and Patent Validation

The balance and game between patent layout and management of innovative drugs and generic drugs

 Patent layout of pharmaceutical companies and industry cross-border overseas strategy

 Patent avoidance and challenges in current generic drug research and development

 The dilemma and development path of patent protection for indications after drug marketing

 Drug new use patent layout strategy and authorization confirmation disputes